News
Food and Drug Administration Commissioner Marty Makary committed to reviewing the abortion drug mifepristone in a letter sent ...
The Trump administration has asked a judge to toss out a lawsuit from three Republican-led states seeking to cut off telehealth access to the abortion medication mifepristone.
The lawsuit was initially rejected by the Supreme Court before it was revived by Republican attorneys general in three states ...
Since the US Supreme Court in 2022 overturned its Roe v. Wade decision establishing a nationwide right to an abortion, the fight over the intervention has focused largely on a pill that ends ...
The Trump administration is cautiously approaching access to abortion medication in a politically sensitive legal battle that ...
Republicans have been laying the groundwork to undermine the safety of mifepristone for months, despite the drug's proven safety record.
The FDA has been tasked with re-evaluating the safety of mifepristone after a flawed report claimed it has a high rate of ...
President Donald Trump’s Department of Justice sided with the Biden administration’s defense of mifepristone on Monday in an ongoing federal lawsuit over the abortion pill. It’s an unexpected move for ...
The filing over the regulation of mifepristone indicates an emerging pattern: An effort to preserve executive power.
Joshua Divine and Maria Lanahan represent the state of Missouri in the most recent challenge to the abortion pill.
On Monday, lawyers for the Trump administration asked a Texas federal judge to toss out a lawsuit in which Missouri, Idaho and Kansas seek to restrict access to the abortion drug mifepristone.
President Donald Trump's administration on Monday pushed forward in defending U.S. rules easing access to the abortion drug mifepristone from a legal challenge that began during Democratic former ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results